A 5-year multi-center, observational post-authorization safety study to document the drug utilisation of Wakix® in the treatment of narcolepsy with or without cataplexy and to collect information on its long termthe safety of Wakix® when used in routine medical practice (WAKIX PASS)

16/06/2016
16/04/2021
EU PAS number:
EUPAS13818
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information